Neuralstem Receives FDA Approval To Commence Spinal Cord Injury Trial

Neuralstem Receives FDA Approval To Commence Spinal Cord Injury Trial. NSI-566 to be tested in patients with chronic spinal cord injury.

Preview image:

URL:

http://www.prnewswire.com/news-releases/neuralstem-receives-fda-approval-to-commence-spinal-cord-injury-trial-186768041.html